These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 6986750)

  • 1. Saralasin infusion in screening patients for renovascular hypertension.
    Krakoff LR; Ribeiro AB; Gorkin JU; Felton KR
    Am J Cardiol; 1980 Mar; 45(3):609-13. PubMed ID: 6986750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Saralasin test as a diagnostic and prognostic aid in renovascular hypertensive patients subjected to renal operation.
    Poutasse EF; Gonzalez-Serva L; Wendelken JR; Franz JP
    J Urol; 1980 Mar; 123(3):306-10. PubMed ID: 6987415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. False-negative saralasin responses in renovascular hypertension.
    Stokes GS; MacCarthy EP; Frost GW; Sheil AG
    Br J Urol; 1979 Apr; 51(2):92-9. PubMed ID: 465980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Saralasin infusion in the recognition of renovascular hypertension.
    Wilson HM; Wilson JP; Slaton PE; Foster JH; Liddle GW; Hollifield JW
    Ann Intern Med; 1977 Jul; 87(1):36-42. PubMed ID: 879617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of renovascular hypertension: saralasin test versus renin determinations.
    Marks LS; Maxwell MH; Smith RB; Cahill PJ; Kaufman JJ
    J Urol; 1976 Oct; 116(4):406-9. PubMed ID: 1053323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of saralasin on blood pressure, renin and renal blood flow in unilateral renovascular hypertension.
    Arlart IP; Rosenthal J; Wagner H; Adam WE; Nobbe F; Franz HE
    Contrib Nephrol; 1978; 11():170-4. PubMed ID: 699587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactive hyperreninemia in renovascular hypertension after angiotensin blockage with saralasin or converting enzyme inhibitor.
    Case DB; Laragh JH
    Ann Intern Med; 1979 Aug; 91(2):153-60. PubMed ID: 464461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of age on diagnostic usefulness of stimulated plasma renin activity and saralasin test in detection of renovascular hypertension.
    Anderson GH; Springer J; Randall P; Streeten DH; Blakeman N
    Lancet; 1980 Oct; 2(8199):821-4. PubMed ID: 6107499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Saralasin infusion in renovascular and essential hypertension.
    Thien T; Hoefnagels WH
    Neth J Med; 1980; 23(2):68-73. PubMed ID: 6990282
    [No Abstract]   [Full Text] [Related]  

  • 10. Reactive hyper-reninaemia to angiotensin blockade identifies renovascular hypertension.
    Case DB; Atlas SA; Laragh JH
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():313s-316s. PubMed ID: 232024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical experience with saralasin infusion in hypertensive patients.
    Tegtmeyer CJ; Latour EA; Vaughan ED; Ayers CR; Carey RM; Wellons HA
    Invest Radiol; 1977; 12(6):496-504. PubMed ID: 591250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Saralasin test as a diagnostic and prognostic aid in renovascular hypertensive patients subjected to renal operation.
    Poutasse EF; Gonzalez-Serva L; Wendelken JR; Franz JP
    Trans Am Assoc Genitourin Surg; 1979; 71():96-100. PubMed ID: 545821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Saralasin infusion in renovascular hypertension: increased response rate in seated patients.
    Tucker RM; Sheps SG; Brennan LA
    Mayo Clin Proc; 1980 Feb; 55(2):99-102. PubMed ID: 7354651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of saralasin to detect renovascular hypertension in childhood.
    Gillespie L; Ehrlich RM; Marks LS; Maxwell MH; Kaufman JJ
    Urology; 1980 Nov; 16(5):453-6. PubMed ID: 7003900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis of angiotensinogenic hypertension: the complementary roles of renal scintigraphy and the saralasin infusion test.
    McAfee JG; Thomas FD; Grossman Z; Streeten DH; Dailey E; Gagne G
    J Nucl Med; 1977 Jul; 18(7):669-75. PubMed ID: 874145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity and specificity of screening tests for renal vascular hypertension.
    Grim CE; Luft FC; Weinberger MH; Grim CM
    Ann Intern Med; 1979 Oct; 91(4):617-22. PubMed ID: 484965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of saralasin on normal blood pressure and on reno-vascular hypertension (author's transl)].
    Beckerhoff R; Vetter W; Furrer J; Nussberger J; Schmied U; Siegenthaler W
    Dtsch Med Wochenschr; 1976 Mar; 101(11):398-401. PubMed ID: 1253700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The Saralasin test in the diagnosis of renovascular hypertension. Personal experience].
    Giuliani L; Martorana G; Giberti C
    Minerva Nefrol; 1979; 26(4):623-8. PubMed ID: 396491
    [No Abstract]   [Full Text] [Related]  

  • 19. Maximal discrimination of renovascular from essential hypertension by the saralasin test.
    Maxwell MH; Varady P; Zawada ET; Burkhalter JF; Waks U; Marks L
    Clin Sci Mol Med Suppl; 1978 Dec; 4():297s-299s. PubMed ID: 282071
    [No Abstract]   [Full Text] [Related]  

  • 20. Screening of angiotensin II dependent hypertensive patients using a linear classifier.
    Koivo AJ
    Med Inform (Lond); 1981; 6(1):19-24. PubMed ID: 7015036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.